2.72 0.08(3.03%)07/05/2024
Lexaria Bioscience Corp (LEXX)
Lexaria Bioscience Corp (LEXX)
Showing latest 10 records. To view more news, Upgrade to PRO plan with only $1
| Headline | Time (ET) | Source |
|---|---|---|
| Lexaria Awards CRO Contract for 12-Week DehydraTECH GLP-1 Chronic Human Study | 06/18 09:00 | accesswire.com |
| Dosing Continues in Lexaria's Second GLP-1 Human Pilot Study | 06/05 09:00 | accesswire.com |
| Dosing Begins in Lexaria's Comprehensive GLP-1 Animal Study | 05/17 09:10 | accesswire.com |
| Lexaria Begins Dosing of Its Second GLP-1 Human Pilot Study | 05/08 09:10 | accesswire.com |
| Lexaria Announces New Research Program to Evaluate Mode of Action and Performance of DehydraTECH-GLP-1 Drugs | 05/06 09:05 | accesswire.com |
| Lexaria to Receive $4.7 Million Gross Proceeds in Warrant Exercise and Issuance | 04/30 15:40 | accesswire.com |
| Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study | 04/16 09:10 | accesswire.com |
| Lexaria Awarded New Patents | 04/02 09:00 | accesswire.com |
| Lexaria to Present at The LD Micro Invitational XIV | 03/21 09:20 | newsfilecorp.com |
| Lexaria Appoints Nelson Cabatuan as Chief Financial Officer | 03/14 09:20 | accesswire.com |